🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03342144
Recruiting Observational

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144 · tracked via the Priya Life Science Germany tracker
Sponsor
AbbVie
Phase
Observational
Started
2017-12-04
Last updated
2026-09-25

Condition(s) studied

Chronic Lymphocytic Leukemia (CLL)

Study summary

An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax as a monotherapy or in combination with rituximab, obinutuzumab, ibrutinib, or acalabrutinib as prescribed at the discretion of the physician and in accordance with local clinical practice and label.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- Participant with chronic lymphocytic leukemia (CLL) who start venetoclax therapy can be included in the study if treated as specified in the local label for any specific line of treatment. Exclusion Criteria: \- None

Primary outcome measure(s)

Trial sites (72)

FacilityCityRegionStatus
Universitaetsklinikum St. Poelten /ID# 221152 Sankt Pölten Lower Austria Completed
Medizinische Universitaet Graz /ID# 221155 Graz Styria Completed
Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 Salzburg Austria Active Not Recruiting
Hanusch Krankenhaus /ID# 221151 Vienna Austria Completed
Stauferklinikum Schwaebisch Gmuend /ID# 201518 Mutlangen Baden-Wurttemberg Completed
Onkologische Praxis /ID# 201545 Stuttgart Baden-Wurttemberg Completed
Schwarzwald-Baar-Klinikum /ID# 208176 Villingen-Schwenningen Baden-Wurttemberg Completed
MVZ am Klinikum Aschaffenburg Onkologie /ID# 201548 Aschaffenburg Bavaria Completed
Studienzentrum Aschaffenburg /ID# 204125 Aschaffenburg Bavaria Completed
Gemeinschaftspraxis Dr. Heinrich und Prof. Bangerter /ID# 200950 Augsburg Bavaria Completed
Drs. Tanzer, Chirca, Stoeberl /ID# 202613 Bad Reichenhall Bavaria Completed
Internistische Schwerpunktpraxen, Erlangen /ID# 200949 Erlangen Bavaria Completed
Onkologie Hof /ID# 201531 Hof Bavaria Completed
Praxis Dr. Stauch /ID# 202611 Kronach Bavaria Completed
VK&K Studien GbR /ID# 202614 Landshut Bavaria Completed
Haemato-Onkologie /ID# 205236 Munich Bavaria Completed
Praxis Dr. Kreher /ID# 202604 Bad Liebenwerda Brandenburg Completed
Praxis Dres. Kiehl/Stein /ID# 210052 Frankfurt (Oder) Brandenburg Completed
MVZ f. Blut- u.Krebserkrankungen /ID# 206704 Potsdam Brandenburg Completed
Ambulantes Tumorzentrum Bremerhaven /ID# 224353 Bremerhaven Free Hanseatic City of Bremen Completed
Centrum fuer Haematologie und Onkologie Bethanien /ID# 206701 Frankfurt am Main Hesse Completed
MVZ Dres. Cordes & Partner /ID# 202598 Frankfurt am Main Hesse Completed
Klinikum Frankfurt Hoechst /ID# 210048 Frankfurt am Main Hesse Completed
Varisano Klinikum Frankfurt Hoechst /ID# 288028 Frankfurt am Main Hesse Recruiting
Onkologische Schwerpunktpraxis Hanau /ID# 287948 Hanau Hesse Recruiting
Praxis Dres. Tebbe/Mayer /ID# 206730 Kassel Hesse Completed
Onkologische Kooperation Harz /ID# 201550 Goslar Lower Saxony Completed
OAZ Hannover /ID# 201538 Hanover Lower Saxony Completed
Onkolologische Praxis Oldenburg /ID# 202607 Oldenburg Lower Saxony Completed
MVZ der Paracelsus-Klinik /ID# 201541 Osnabrück Lower Saxony Completed
Med. Studiengesellschaft Nord West GmbH /ID# 201535 Westerstede Lower Saxony Completed
Praxis Dres. Plewe/Losem /ID# 202606 Neuss North Rhine-Westphalia Completed
Hämatologie und Onkologie /ID# 205247 Kaiserslautern Rhineland-Palatinate Completed
Praxis Dr. Klaproth/Cura /ID# 216413 Neunkirchen Saarland Completed
Onkozentrum Dresden /ID# 202599 Dresden Saxony Completed
BAG Freiberg-Richter, Jacobasch, Illmer, Wolf /ID# 201532 Dresden Saxony Completed
Evidia MVZ III Oncology Halle /ID# 218354 Halle Saxony-Anhalt Completed
Luebecker Oncology Practice /ID# 200952 Lübeck Schleswig-Holstein Completed
Friedrich-Ebert-Krankenhaus GmbH /ID# 206206 Neumünster Schleswig-Holstein Completed
Praxis Dres. Krober/Stosiek /ID# 206729 Regensburg State of Berlin Completed

+ 32 more sites — see the full list on the official registry below.

More AbbVie trials in Germany

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia Active, not recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer Recruiting
A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma Active, not recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer Recruiting

Other trials for the same condition

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) Recruiting
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03342144 on ClinicalTrials.gov ↗ ← All trials in Germany